Detalles de la búsqueda
1.
The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study.
Cancer Chemother Pharmacol
; 88(1): 81-88, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772633
2.
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.
Cancer Manag Res
; 13: 6207-6218, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408488
3.
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.
Clin Cancer Res
; 27(13): 3649-3660, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33879458
Resultados
1 -
3
de 3
1
Próxima >
>>